The results in Table 6 showed that BGN expression was remarkably correlated with pathologic stage (p = 0.008), T stage (p = 0.001), histologic type (p < 0.001), and histological grade (p = 0.025) in 80 GC patients who underwent immunohistochemistry, but was not significantly associated with gender (p = 0.802), N stage (p = 0.232), residual tumor (p = 0.323), primary therapy outcome (p = 0.655), anatomic neoplasm subdivision (p = 0.905), and age (p = 0.600). Here, BGN is linked to gastric cancer.